Inspire Investing, LLC Amneal Pharmaceuticals, Inc. Transaction History

Inspire Investing, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$4.31 - $5.64 $192,863 - $252,378	-44,748 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$5.12 - $6.82 $6,942 - $9,247	1,356 Added 3.13%	44,748 $229,000
Q1 2021 Apr 30, 2021	SELL	$4.74 - $7.38 $13,850 - $21,564	-2,922 Reduced 6.31%	43,392 $292,000
Q4 2020 Feb 12, 2021	BUY	$3.95 - $5.42 $62,212 - $85,365	15,750 Added 51.53%	46,314 $212,000
Q3 2020 Nov 16, 2020	SELL	$3.54 - $5.27 $36,440 - $54,249	-10,294 Reduced 25.19%	30,564 $119,000
Q2 2020 Aug 12, 2020	SELL	$2.87 - $5.46 $50,695 - $96,445	-17,664 Reduced 30.18%	40,858 $194,000
Q1 2020 May 08, 2020	BUY	$2.46 - $5.35 $143,964 - $313,092	58,522 New	58,522 $204,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.27B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.